Targeting the OXNAD1–PTGS2 axis with resveratrol overcomes ferroptosis Inhibition and reverses 5-FU resistance in gastric cancer
Gastric Cancer · 2026-05 · 29 (3) · 561-577
DOI: 10.1007/s10120-026-01718-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Gastric Cancer, online erschienen am 13.03.2026. Verfasst von Jinzhou Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China. wangjz@fjmu.edu.cn. Hauptthemen laut MEDLINE: Stomach Neoplasms, Resveratrol, Ferroptosis, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: 2021 Fujian Province Mid-career and Young Teachers Education Research Project(Science and Technology), Joint Funds for the Innovation of Science and Technology, Fujian Province, 2021 Fujian Province Mid-career and Young Teachers Education Research Projec.
Abstract (Originalsprache)
BACKGROUND: 5-Fluorouracil (5-FU) remains a cornerstone of first-line chemotherapy for gastric cancer, yet the emergence of resistance severely compromises its clinical efficacy. Although ferroptosis suppression has been recognized as a pivotal mechanism of chemoresistance, the mitochondrial regulatory processes involved remain poorly understood. METHODS: We integrated clinical specimen analysis, in vitro and in vivo functional assays, multi-omics profiling, and molecular docking to delineate the role of the mitochondrial oxidoreductase OXNAD1 in mediating 5-FU resistance in gastric cancer, and to assess the therapeutic potential of the natural polyphenol resveratrol as a chemosensitizing agent. RESULTS: OXNAD1 was found to be significantly overexpressed in gastric cancer tissues and cell lines, correlating with unfavorable prognosis and enhanced 5-FU resistance. Mechanistically, OXNAD1 directly bound to and suppressed the ferroptosis driver PTGS2, thereby attenuating lipid peroxidation and mitochondrial damage, ultimately restraining ferroptosis and promoting drug resistance. Notably, resveratrol disrupted the OXNAD1-PTGS2 interaction by directly binding OXNAD1, reinstating ferroptotic activity, markedly enhancing the cytotoxic effect of 5-FU in resistant cells, and potentiating the antitumor efficacy of 5-FU in xenograft models. CONCLUSION: The OXNAD1-PTGS2 axis constitutes a critical metabolic-cell death cross-regulatory pathway underlying 5-FU resistance in gastric cancer. Targeting this axis with resveratrol provides a promising combinatorial strategy to overcome chemoresistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China. wangjz@fjmu.edu.cn.
- Department of Gastrointestinal Surgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350212, China. wangjz@fjmu.edu.cn.
- Department of Pharmacy, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350212, China.
- Department of Pharmacy, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China.
- Department of General Surgery, Zhongshan Hospital, Fudan University School of Medicine, Shanghai, China.
- Department of Gastrointestinal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China.
Förderung
- 2021 Fujian Province Mid-career and Young Teachers Education Research Project(Science and Technology)
- Joint Funds for the Innovation of Science and Technology, Fujian Province
- 2021 Fujian Province Mid-career and Young Teachers Education Research Projec
Zitieren
APA
Wang, J., Xu, B., Lin, X., Chen, B., Liu, X., & Wu, W. (2026). Targeting the OXNAD1–PTGS2 axis with resveratrol overcomes ferroptosis Inhibition and reverses 5-FU resistance in gastric cancer. Gastric Cancer, 29(3), 561-577. https://doi.org/10.1007/s10120-026-01718-x
Vancouver
Wang J, Xu B, Lin X, Chen B, Liu X, Wu W. Targeting the OXNAD1–PTGS2 axis with resveratrol overcomes ferroptosis Inhibition and reverses 5-FU resistance in gastric cancer. Gastric Cancer. 2026;29(3):561-577. doi:10.1007/s10120-026-01718-x
BibTeX
@article{Wang2026,
author = {Wang, Jinzhou and Xu, Bishuang and Lin, Xiaohan and Chen, Biyu and Liu, Xiaoyan and Wu, Wei},
title = {Targeting the OXNAD1–PTGS2 axis with resveratrol overcomes ferroptosis Inhibition and reverses 5-FU resistance in gastric cancer},
journal = {Gastric Cancer},
year = {2026},
volume = {29},
number = {3},
pages = {561--577},
doi = {10.1007/s10120-026-01718-x}
}
EUVIMED